Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna P Andreou

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Pain|August 16, 2020
Differential actions of indomethacin: clinical relevance in headacheOliver Summ, Anna P Andreou, Simon Akerman, et al.
Ebiomedicine|December 24, 2023
Resistant and refractory migraine: clinical presentation, pathophysiology, and managementRaffaele Ornello, Anna P Andreou, Eleonora De Matteis, et al.
Annals of Neurology|October 31, 2012
Acid-sensing ion channel 1: a novel therapeutic target for migraine with auraPhilip R Holland, Simon Akerman, Anna P Andreou, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 10, 2023
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World AnalysisGiorgio Lambru, Valeria Caponnetto, Bethany Hill, et al.
Pain and Therapy|November 28, 2020
Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and MigraineGiorgio Lambru, Silvia Benemei, Anna P Andreou, et al.
BMC Neurology|May 17, 2023
The increasing role of electronic media in headacheThien Phu Do, Anna P Andreou, Arao Belitardo de Oliveira, et al.
The Journal of Headache and Pain|October 31, 2025
A prospective real-world analysis of intravenous eptinezumab in migraine management: the first UK experienceAnna P Andreou, Bethany Hill, Rand Al-Rawi, et al.
Neurobiology of Disease|December 3, 2014
Evidence for orexinergic mechanisms in migraineJan Hoffmann, Weera Supronsinchai, Simon Akerman, et al.
Journal of Clinical Medicine|April 13, 2024
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic ReviewDimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, et al.
The Journal of Headache and Pain|January 20, 2026
Noradrenergic system involvement as a major driver of tension-type headache: a systematic review of the current evidenceSimone Braca, Gennaro Cretella, Christina Deligianni, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Pain|August 16, 2020
Differential actions of indomethacin: clinical relevance in headacheOliver Summ, Anna P Andreou, Simon Akerman, et al.
Ebiomedicine|December 24, 2023
Resistant and refractory migraine: clinical presentation, pathophysiology, and managementRaffaele Ornello, Anna P Andreou, Eleonora De Matteis, et al.
Annals of Neurology|October 31, 2012
Acid-sensing ion channel 1: a novel therapeutic target for migraine with auraPhilip R Holland, Simon Akerman, Anna P Andreou, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 10, 2023
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World AnalysisGiorgio Lambru, Valeria Caponnetto, Bethany Hill, et al.
Pain and Therapy|November 28, 2020
Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and MigraineGiorgio Lambru, Silvia Benemei, Anna P Andreou, et al.
BMC Neurology|May 17, 2023
The increasing role of electronic media in headacheThien Phu Do, Anna P Andreou, Arao Belitardo de Oliveira, et al.
The Journal of Headache and Pain|October 31, 2025
A prospective real-world analysis of intravenous eptinezumab in migraine management: the first UK experienceAnna P Andreou, Bethany Hill, Rand Al-Rawi, et al.
Neurobiology of Disease|December 3, 2014
Evidence for orexinergic mechanisms in migraineJan Hoffmann, Weera Supronsinchai, Simon Akerman, et al.
Journal of Clinical Medicine|April 13, 2024
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic ReviewDimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, et al.
The Journal of Headache and Pain|January 20, 2026
Noradrenergic system involvement as a major driver of tension-type headache: a systematic review of the current evidenceSimone Braca, Gennaro Cretella, Christina Deligianni, et al.
Pageof 6